EUVIMEDEUVIMED entdecken
EditorialOpen Access

BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†

Arun K Ghosh

Global Health & Medicine · 30.06.2024 · 6 (3) · 164-169

DOI: 10.35772/ghm.2024.01033 ↗

Kurz gefasst

Editorial in der Zeitschrift Global Health & Medicine, erschienen am 30.06.2024. Verfasst von Arun K Ghosh. Beteiligte Einrichtung: Departments of Chemistry, Purdue University, West Lafayette, IN, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer diseaseBACE1amyloiddrug developmentinhibitor

Autor:innen und Institutionen

  • Departments of Chemistry, Purdue University, West Lafayette, IN, USA.
  • Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.

Zitieren

APA

Ghosh, A. K. (2024). BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†. Global Health & Medicine, 6(3), 164-169. https://doi.org/10.35772/ghm.2024.01033

Vancouver

Ghosh AK. BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†. Global Health & Medicine. 2024;6(3):164-169. doi:10.35772/ghm.2024.01033

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Arun K},
  title = {BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†},
  journal = {Global Health & Medicine},
  year = {2024},
  volume = {6},
  number = {3},
  pages = {164--169},
  doi = {10.35772/ghm.2024.01033}
}
Kostenlos starten →